LifeMap Sciences Limited

Company Overview

Snapshot

Founded in April 2011, LifeMap Sciences Limited operates with 1–10 employees. The company ceased operations in March 2025, marking a significant operational change.

Business overview

LifeMap Sciences develops and commercializes the GeneCards Suite Knowledgebase, an integrated biomedical database. This technology consolidates information from over 120 sources, enabling researchers to navigate human genes, genetic variants, proteins, cells, biological pathways, diseases, and their interrelationships. The company serves the health tech and life sciences sectors, focusing on digital healthcare and medical decision support.

Strategic signal

LifeMap Sciences ceased operations in March 2025. This indicates a complete strategic shift and the discontinuation of its business activities, signaling to investors and innovation teams that the company is no longer an active entity in the health tech and life sciences market.

Company Intelligence Q&A

What is the primary product of LifeMap Sciences?

LifeMap Sciences develops and commercializes the GeneCards Suite Knowledgebase, an integrated biomedical database that compiles information from over 120 sources to assist researchers.

When did LifeMap Sciences cease its operations?

LifeMap Sciences ceased to operate in March 2025.

What was the strategic focus of LifeMap Sciences?

LifeMap Sciences focused on providing tools for effective navigation of human genes, genetic variants, proteins, cells, biological pathways, diseases, and their relationships within the health tech and life sciences sectors.

What was a notable partnership for LifeMap Sciences in 2019?

In March 2019, LifeMap Sciences announced a strategic collaboration with iCarbonX Research Shenzhen.

What was a key product launch by LifeMap Sciences in 2016?

In January 2016, LifeMap Sciences announced the launch of TGexTM, a knowledge-driven NGS analysis platform powered by the GeneCards Suite.